Outset Medical Inc. (OM)
0.81
0.00 (0.27%)
At close: Jan 14, 2025, 3:59 PM
0.86
6.29%
Pre-market Jan 15, 2025, 04:20 AM EST
undefined% (undefined)
| Bid | 0.78 |
| Market Cap | 43.09M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -2.74 |
| PE Ratio (ttm) | -0.3 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 0.86 |
| Volume | 1,844,144 |
| Avg. Volume (20D) | 1,011,801 |
| Open | 0.80 |
| Previous Close | 0.81 |
| Day's Range | 0.76 - 0.83 |
| 52-Week Range | 0.43 - 5.22 |
| Beta | undefined |
About OM
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015...
Industry Medical - Devices
Sector Healthcare
IPO Date Sep 15, 2020
Employees 480
Stock Exchange NASDAQ
Ticker Symbol OM
Website https://www.outsetmedical.com
Analyst Forecast
According to 3 analyst ratings, the average rating for OM stock is "Buy." The 12-month stock price forecast is $3, which is an increase of 268.64% from the latest price.
Buy 66.67%
Hold 33.33%
Sell 0.00%
Next Earnings Release
Outset Medical Inc. is scheduled to release its earnings on Feb 19, 2025,
during market hours.
Analysts project revenue of $27.79M, reflecting a -8.91% YoY shrinking and earnings per share of -0.37, making a -37.29% decrease YoY.
Analysts project revenue of $27.79M, reflecting a -8.91% YoY shrinking and earnings per share of -0.37, making a -37.29% decrease YoY.
2 months ago ·
Source
+25.18%
Outset Medical shares are trading higher after the...
Unlock content with
Pro Subscription
5 months ago ·
Source
-68.53%
Outset Medical shares are trading lower after the company reported worse-than-expected Q2 financial results and cut its FY24 revenue guidance.
